Skip to main content
Log in

Proliferation markers in gliomas: A comparison of BUDR, KI-67, and MIB-1

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Hoshino T, Rodriguez LA, Cho KG, Lee KS, Wilson CB, Edwards MSB, Levin VA, Davis RL: Prognostic implications of the proliferative potential of lowgrade astrocytomas. J Neurosurg 69: 839–842, 1988

    Google Scholar 

  2. Ito S, Chandler KL, Prados MD, Lamborn K, Wynne J, Malec MK, Wilson CB, Davis RL, Hoshino T: Proliferative potential and prognostic evaluation of low-grade astrocytomas. J of Neuro-Oncology 19: 1–9, 1994

    Google Scholar 

  3. Onda K, Davis RL, Wilson CB, Hoshino T: Regional differences in bromodeoxyuridine uptake, expression of Ki-67 protein, and nucleolar organizer region counts in glioblastoma multiforme. Acta Neuropathol (Berlin) 87: 586–593, 1994

    Google Scholar 

  4. Onda K, Davis RL, Shibuya M, Wilson CB, Hoshino T: Correlation between bromodeoxyuridine labeling index and MIB1 and KI-67 proliferating cell indices in cerebral gliomas: MIB 1 immunohistochemistry as a proliferation marker. Cancer 1994

  5. Onda K, Davis RL, Edwards MSB: Regional difference of growth potential in medulloblastomas: double immunohistochemical staining using anti-bromodeoxyuridine and MIB 1 monoclonal antibodies. J Neurooncology, submitted

  6. Wacker M, Hoshino T, Ahn DK, Davis RL, Prados MD: The prognostic implications of histologic classification and bromodeoxyuridine labeling index of mixed gliomas. J of Neuro-Oncology 19: 113–122, 1994

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Davis, R.L., Onda, K., Shubuya, M. et al. Proliferation markers in gliomas: A comparison of BUDR, KI-67, and MIB-1. J Neuro-Oncol 24, 9–12 (1995). https://doi.org/10.1007/BF01052651

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01052651

Key words

Navigation